BÜHLMANN, a company based in Germany, launched IBDoc, an at-home, in-vitro diagnostic test for gastrointestinal conditions, including some inflammatory bowel diseases, according to an IBD News Today report.
The kit allows people to measure the fecal inflammation marker calprotectin at home. The gastrointestinal inflammation can indicate IBD conditions, such as Crohn's disease and ulcerative colitis. The testing kit combines a stool extraction device called CALEX, a calprotectin test strip and an IBDoc smart phone app. Patients are able to read the results via an image and let their healthcare providers know via the internet, according to the report.